Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol
- 1 January 1997
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (1), 93-97
- https://doi.org/10.1016/s0015-0282(97)81862-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Assisted hatching in the treatment of poor prognosis in vitro fertilization candidatesFertility and Sterility, 1994
- Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilizationFertility and Sterility, 1994
- Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilizationHuman Reproduction, 1991
- Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder womenFertility and Sterility, 1991
- Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMGJournal of Assisted Reproduction and Genetics, 1991
- The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian responseFertility and Sterility, 1991
- High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patientsFertility and Sterility, 1990
- Gonadotropin suppression with oral contraceptives before in vitro fertilizationFertility and Sterility, 1990
- Evolution of a highly successful in vitro fertilization-embryo transfer programFertility and Sterility, 1987
- The program for in vitro fertilization at NorfolkFertility and Sterility, 1982